A new class of compound for pancreatic carcinoma targeting the tyrosine kinase receptor (TKR) ROR1.
Hakan Mellstedt
Employment or Leadership Position - Kancera
Consultant or Advisory Role - Kancera
Stock Ownership - Kancera
Amir Hossein Daneshmanesh
Stock Ownership - Kancera
Ali Moshfegh
Stock Ownership - Kancera
Mohammad Hojat Farsangi
Stock Ownership - Kancera
Salam Khan
No relevant relationships to disclose
Eva Mikaelsson
No relevant relationships to disclose
Jan Vagberg
Employment or Leadership Position - Kancera
Styrbjorn Bystrom
Employment or Leadership Position - Kancera
Johan Schultz
Employment or Leadership Position - Kancera
Thomas Olin
Employment or Leadership Position - Kancera
Stock Ownership - Kancera
Anders Österborg
Consultant or Advisory Role - Kancera